Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bioventus Q1 Adj. EPS $0.08 Beats $0.02 Estimate, Sales $123.88M Beat $122.70M Estimate

Author: Benzinga Newsdesk | May 06, 2025 06:31am
Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.02 by 300 percent. This is a 14.29 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $123.88 million which beat the analyst consensus estimate of $122.70 million by 0.96 percent. This is a 4.31 percent decrease over sales of $129.46 million the same period last year.

Posted In: BVS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist